US Stock MarketDetailed Quotes

VKTX Viking Therapeutics

Watchlist
  • 65.850
  • +0.470+0.72%
Close Oct 16 16:00 ET
  • 65.800
  • -0.050-0.08%
Post 19:52 ET
7.30BMarket Cap-70806P/E (TTM)

Viking Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viking Therapeutics Q3 2024 Estimates Date

Currency：USDOct 23, 2024

Estimate YoY
Revenue
0
--
EPS
-0.25
-8.13%
Analyst Rating
Strong Buy

Oct 16, 2024

Viking Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
Oct 23, 20242024/Q3-- / 0.000--
Jul 24, 20242024/Q20.000 / 0.000--
Apr 24, 20242024/Q10.000 / 0.000--
Feb 7, 20242023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
Oct 23, 20242024/Q3-- / 0.000--
Jul 24, 20242024/Q20.000 / 0.000--
Apr 24, 20242024/Q10.000 / 0.000--
Feb 7, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Viking Therapeutics Earnings Reports

  • Viking Therapeutics | 10-Q: Q2 2024 Earnings Report

    Jul 24 17:05 ET

  • Viking Therapeutics | 10-Q: Q1 2024 Earnings Report

    Apr 25 15:24 ET

  • Viking Therapeutics | 10-K: FY2023 Annual Report

    Feb 7 17:27 ET

  • Viking Therapeutics | 10-Q: Q3 2023 Earnings Report

    Oct 25, 2023 17:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 16, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Weight Loss Drugs
    Weight Loss Drugs
    Intraday+0.20%